Seeking Alpha

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

LYON, France, March 4, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced today that its Focal One platform has been granted Breakthrough Device designation by ...
CNN

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

LYON, France,January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...
Seeking Alpha

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

LYON, France, January 31, 2022 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study ...
Business Insider

EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil

HIFU Prostate Cancer Treatments Successfully Performed at Albert Einstein Hospital, Sao Paulo LYON, France, September 27, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound ...
Mena FN

Industry Analysis: 5-In-1 HIFU Technology And China's Export-Oriented Manufacturing Landscape

(MENAFN- EIN Presswire) EINPresswire/ -- I. Company Overview: Huamei's Leadership in Advanced Aesthetic Technology Located in Shandong, China, Shandong Huamei Technology Co., Ltd. has established ...